富創精密(688409.SH):公司是全球為數不多能夠量產應用於7納米工藝製程半導體設備的精密零部件製造商
格隆匯4月28日丨有投資者在投資者互動平台向富創精密(688409.SH)提問,“作為半導體設備零部件平台公司,在美國禁止出口零部件給中國的前提下,貴公司有沒有能力補上國外公司的空白?另外現階段國內芯片設備零部件國產化率多少?”
富創精密回覆稱,公司是全球為數不多的能夠量產應用於7納米工藝製程半導體設備的精密零部件製造商。公司將在現有產品的基礎上逐步實現半導體設備精密零部件的國產化,助力國內半導體設備企業實現關鍵設備的自主可控。未來公司將持續加大技術研發投入、加快智能化柔性化工廠建設進度和客户開拓,積極參與到客户新產品的開發設計過程;通過與客户共同設計、聯合開發,進一步提升技術水平和市場競爭力,使公司的產品實現從精密零部件到組件再到複雜模塊的結構優化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.